GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » EVE Health Group Ltd (ASX:EVE) » Definitions » YoY EBITDA Growth

EVE Health Group (ASX:EVE) YoY EBITDA Growth : 16.67% (As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is EVE Health Group YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. EVE Health Group's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 16.67%.

EVE Health Group's EBITDA per Share for the six months ended in Dec. 2024 was A$-0.01.

EVE Health Group YoY EBITDA Growth Historical Data

The historical data trend for EVE Health Group's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EVE Health Group YoY EBITDA Growth Chart

EVE Health Group Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.14 3.45 -78.57 66.00 35.29

EVE Health Group Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.69 75.00 45.45 16.67 16.67

EVE Health Group YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

EVE Health Group's YoY EBITDA Growth for the fiscal year that ended in Jun. 2024 is calculated as:

YoY EBITDA Growth (A: Jun. 2024 )
=(EBITDA per Share (A: Jun. 2024 )-EBITDA per Share (A: Jun. 2023 ))/ | EBITDA per Share (A: Jun. 2023 ) |
=(-0.011--0.017)/ | -0.017 |
=35.29 %

EVE Health Group's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(-0.005--0.006)/ | -0.006 |
=16.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EVE Health Group YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of EVE Health Group's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

EVE Health Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » EVE Health Group Ltd (ASX:EVE) » Definitions » YoY EBITDA Growth
Comparable Companies
ASX:OMG ASX:NGS ASX:PFT ASX:TFL ASX:CCO ASX:WOA ASX:WNX ASX:HCT XSWX:NESN XPAR:BN JBS SHSE:603288 KHC NSE:NESTLEIND K GIS TSE:2802 SHSE:600887 SZSE:300999 MKC
Traded in Other Exchanges
N/A
Address
245 Churchill Avenue, Suite 1, Subiaco, WA, AUS, 6008
Website
https://www.evehealthgroup.com.au
EVE Health Group Ltd is an integrated, Health, Nutrition, and Wellness investment company. The company operates in three reporting segments namely Meluka (branded wellness consumer products), Investments and Discontinued Operations.